Analysis of Latin America’s pain-relief drug market—including NSAIDs, opioids, and more—forecasting growth from US$ 4.07 B (2024) to US$ 6.58 B by 2033 at a 5.6% CAGR https://www.datamintelligence.com/research-report/latin-america-pain-management-drugs-market